These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4844928)

  • 21. [Trial of benzphetamine in treatment of obesity].
    Plauchu M; Chapuy H; Pousset G; Amourdedieu J; Tuaillon J
    Lyon Med; 1969 Sep; 222(32):317-20. PubMed ID: 5398817
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of obesity with "Redukal"].
    Ziegler A
    Dtsch Gesundheitsw; 1971 Jul; 26(27):1247-51. PubMed ID: 5093314
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of obesity with a new lipolytic and anorexigenic drug: phenproporex].
    Luquero Campos F
    Rev Esp Enferm Apar Dig; 1971 Apr; 34(1):91-8. PubMed ID: 5564856
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of phenethylbiguanide on body weight and some serum lipid indices in obese subjects, obese diabetics and obese subjects with potential diabetes].
    Pompei A; Marcenaro A; Foppiani E; Jacopino GE
    Clin Ter; 1969 Dec; 51(6):541-60. PubMed ID: 5371379
    [No Abstract]   [Full Text] [Related]  

  • 25. A treatment for refractory obesity using fenfluramine without dietary restriction.
    Sedgwick JP
    Br J Clin Pract; 1970 Jun; 24(6):251-2. PubMed ID: 5456744
    [No Abstract]   [Full Text] [Related]  

  • 26. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties.
    Elliott BW
    Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controlled clinical trials of a new appetite-inhibiting drug].
    Bani G; Barba C; Ricci G
    Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726
    [No Abstract]   [Full Text] [Related]  

  • 28. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of desopimon on the coagulation system of the blood in obesity].
    Vasiukova EA; Pisarskaia IV; Sharova IuA
    Ter Arkh; 1972 Sep; 44(9):92-5. PubMed ID: 4660414
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of obesity in the Bantu: value of a low-carbohydrate diet with and without an appetite suppressant.
    Kew MC
    S Afr Med J; 1970 Sep; 44(35):1006-7. PubMed ID: 5469433
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinically controlled trial of Perphoxene].
    Barbey JD
    Schweiz Rundsch Med Prax; 1971 Sep; 60(37):1242-6. PubMed ID: 4937701
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative trial of fenfluramine and diethylpropion inbesity.
    Silverstone JT; Cooper RM; Begg RR
    Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
    [No Abstract]   [Full Text] [Related]  

  • 34. Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy.
    Sletten IW; Ognjanov V; Menendez S; Sundland D; el-Toumi A
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):570-5. PubMed ID: 4965506
    [No Abstract]   [Full Text] [Related]  

  • 35. [Weight loss lowers blood pressure, lipids and blood glucose. Sibutramine also helps diabetics with weight loss].
    MMW Fortschr Med; 2002 Sep; 144(37):56. PubMed ID: 12380343
    [No Abstract]   [Full Text] [Related]  

  • 36. [Increase of energy transformation by hexoprenaline].
    Irsigler K; Schlick W; Schütz P
    Arzneimittelforschung; 1971 Jan; 21(1):51-4. PubMed ID: 5108200
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 38. Double-blind trial of anorectic agents.
    Sproule BC
    Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
    Follows OJ
    Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
    [No Abstract]   [Full Text] [Related]  

  • 40. [Model for clinico-pharmacological experimentation with an appetite depressant. Clinical trial with a delayed-action preparation].
    Strata A; Cucurachi L; Cucurachi P; Dell'anna A; Zuliani U
    Clin Ter; 1968 Mar; 44(6):495-516. PubMed ID: 4899457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.